This article is more than 5 years old. Information may no longer be current.

VIDEO: Speaker reviews evolving roles of screening, surveillance for melanoma

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK — Allen C. Halpern, MD, MsC, chief of dermatology at Memorial Sloan Kettering Cancer Center, discussed the current state of screening for melanoma and the importance of surveillance and early intervention for those already diagnosed at HemOnc Today Melanoma and Cutaneous Malignancies.

“We reviewed the current lack of recommendations for general public screening, with the interesting data coming out in Germany about public screening for melanoma. At a minimum, we should be doing intensive surveillance in the very high-risk population,” he told HemOnc Today.